Markets:

Overview

News

Currencies

International

Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.280 +0.020 (+1.59%)

Official Closing Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Geron (GERN) Q1 2023 Earnings Call Transcript ↗

May 11, 2023

GERN earnings call for the period ending March 31, 2023.

Via The Motley Fool

Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

May 11, 2023

From Geron Corporation

Via Business Wire

Recap: Geron Q1 Earnings ↗

May 11, 2023

Via Benzinga

Geron Corporation Reports First Quarter 2023 Financial Results and Business Highlights

May 11, 2023

From Geron Corporation

Via Business Wire

A Preview Of Geron's Earnings ↗

May 10, 2023

Via Benzinga

Looking Into Geron's Return On Capital Employed ↗

March 17, 2023

Via Benzinga

The Latest Analyst Ratings for Geron ↗

March 17, 2023

Via Benzinga

Geron (GERN) Q4 2022 Earnings Call Transcript ↗

March 16, 2023

GERN earnings call for the period ending December 31, 2022.

Via The Motley Fool

Geron to Announce First Quarter 2023 Financial Results on May 11, 2023

May 04, 2023

From Geron Corporation

Via Business Wire

Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial

April 26, 2023

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 20, 2023

From Geron Corporation

Via Business Wire

Earnings Outlook For Geron ↗

March 15, 2023

Via Benzinga

2 Top Healthcare Stocks to Buy Right Now ↗

February 13, 2023

One has a breakout drug, the other a nice-sized moat.

Via The Motley Fool

Why Shares of Geron Are Up 30% This Week ↗

April 20, 2023

The company's CEO was scheduled to speak at a virtual conference on Thursday.

Via The Motley Fool

Geron to Present at Upcoming Investor Conferences in April

April 12, 2023

From Geron Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023 ↗

March 28, 2023

Via Benzinga

7 Biotech Stocks Sitting in the Sweet Spot ↗

March 24, 2023

Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.

Via InvestorPlace

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 16, 2023

From Geron Corporation

Via Business Wire

Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones

March 16, 2023

From Geron Corporation

Via Business Wire

Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023

March 09, 2023

From Geron Corporation

Via Business Wire

SMID Cap Life Science Update: Are You An Investor Or Trader? ↗

February 20, 2023

Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.

Via Talk Markets

7 A-Rated Penny Stocks Worth Betting On ↗

February 19, 2023

Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.

Via InvestorPlace

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 16, 2023

From Geron Corporation

Via Business Wire

7 A-Rated Healthcare Stocks to Buy for the Future of Medicine ↗

February 12, 2023

Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.

Via InvestorPlace

7 A-Rated Stocks to Buy for February 2023 ↗

February 07, 2023

Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader.

Via InvestorPlace

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

7 A-Rated Stocks to Buy for Less Than $25 ↗

January 24, 2023

These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.

Via InvestorPlace

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 19, 2023

From Geron Corporation

Via Business Wire

Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference

January 12, 2023

From Geron Corporation

Via Business Wire

Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.

January 11, 2023

From Geron Corporation

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Geron Corporation - Common Stock (NQ:GERN)

All News about Geron Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today